Eyal Baror is the CEO and President of Neuronix Ltd., which developed the first medical device for the treatment of Alzheimer’s Disease. Eyal has been leading Neuronix since 2009, starting with the early scientific concept, developing Neuronix therapy system, demonstrating its efficacy through series of rigorous clinical studies, obtaining regulatory approvals and launching commercial activity.
Eyal brings over 20 years of experience, including holding key management positions in various medical devices companies. Previously, Eyal gained extensive R&D experience while serving in the Israeli Intelligence R&D Branch.
Eyal is a graduate of the prestigious Israel Defense Forces TALPIOT program, holds a B.Sc. in Physics & Mathematics (cum-laude) from the Hebrew University of Jerusalem, and a M.Sc. in Physics (summa cum laude) from the Tel-Aviv University.